Literature DB >> 24529848

Evaluation of Annexin A7, Galectin-3 and Gelsolin as possible biomarkers of hepatocarcinoma lymphatic metastasis.

Xianyan Wang1, Lulu Bai2, Mohammed Mohammed Ibrahim2, Wei Ma3, Jun Zhang2, Yuhong Huang2, Bo Wang2, Lin Song2, Jianwu Tang4.   

Abstract

We have previously demonstrated that Annexin A7 is involved in the lymphatic metastasis of hepatocarcinoma in vitro. The expression of Galectin-3 and Gelsolin, which were also relevant to tumor lymphatic metastasis, had shown the same tendency concordantly with the expression of Annexin A7 alteration by qRT-PCR and Western blot analysis. Here, we gain an insight into the role that Annexin A7 is playing in Hca-P, PAnxa7-upregulated and PAnxa7-downregulated cells in vivo. Then, Hca-P, PAnxa7-upregulated and PAnxa7-downregulated cells were injected into a mouse footpad to establish primary tumors in mice. On the fourth week after HCC cells inoculation, the mice were sacrificed for inspection the expression of Annexin A7, Galectin-3 and Gelsolin in primary tumors and in serum. Our work indicates that Annexin A7 and Gelsolin are both valuable in tumors and in serum evaluating lymph node metastasis in mice with hepatocarcinoma; Galectin-3 in tumors is significant but no much contribution in serum.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Animal experiment; Annexin A7 (ANXA7 or synexin); Lymphatic metastasis; Metastasis associated biomarkers

Mesh:

Substances:

Year:  2014        PMID: 24529848     DOI: 10.1016/j.biopha.2013.12.009

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

Review 1.  Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).

Authors:  Rui Dong; Min Zhang; Qunying Hu; Shan Zheng; Andrew Soh; Yijie Zheng; Hui Yuan
Journal:  Int J Mol Med       Date:  2017-12-05       Impact factor: 4.101

2.  High co-expression of the SDF1/CXCR4 axis in hepatocarcinoma cells is regulated by AnnexinA7 in vitro and in vivo.

Authors:  Jingwen Wang; Yuhong Huang; Jun Zhang; Boyi Xing; Wei Xuan; Honghai Wang; He Huang; Jiayu Yang; Jianwu Tang
Journal:  Cell Commun Signal       Date:  2018-05-21       Impact factor: 5.712

3.  A prognostic model for hepatocellular carcinoma based on apoptosis-related genes.

Authors:  Renjie Liu; Guifu Wang; Chi Zhang; Dousheng Bai
Journal:  World J Surg Oncol       Date:  2021-03-12       Impact factor: 2.754

4.  Leptin Receptor (LEPR) promotes proliferation, migration, and invasion and inhibits apoptosis in hepatocellular carcinoma by regulating ANXA7.

Authors:  He Huang; Jun Zhang; Fei Ling; Yuhong Huang; Min Yang; Yao Zhang; Yuanyi Wei; Qingqing Zhang; Honghai Wang; Lin Song; Ying Wu; Jiayu Yang; Jianwu Tang
Journal:  Cancer Cell Int       Date:  2021-01-04       Impact factor: 5.722

5.  AnnexinA7 promotes epithelial-mesenchymal transition by interacting with Sorcin and contributes to aggressiveness in hepatocellular carcinoma.

Authors:  Fei Ling; Huan Zhang; Yunliang Sun; Jinyi Meng; Jaceline Gislaine Pires Sanches; He Huang; Qingqing Zhang; Xiao Yu; Bo Wang; Li Hou; Jun Zhang
Journal:  Cell Death Dis       Date:  2021-10-29       Impact factor: 8.469

6.  Long Noncoding RNAs Coregulated by Annexin A7 and JNK in Hepatocellular Carcinoma Cells Identified by Whole-Genome Expression Profiling.

Authors:  Qi Deng; Lianhong Li; Yanling Jin
Journal:  Biomed Res Int       Date:  2020-07-25       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.